AtriCure Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.47
Market Cap
$1.21 B
Shares Outstanding
38.62 M
Public Float
36.75 M

Profile

Address
7555 Innovation Way
Mason Ohio 45069
United States
Employees -
Website http://www.atricure.com
Updated 07/08/2019
AtriCure, Inc. engages provision of treatment of atrial fibrillation and left atrial appendage. It operates through the following geographical segments: United States, Europe, Asia, and Other International. Its product, Isolator Synergy Ablation System, is a surgical device that treats the persistent longstanding persistent forms of atrial fibrillation in patients undergoing certain open concomitant procedures.

Financials

View All

Michael H. Carrel
President, Chief Executive Officer & Director
Scott William Drake
Chairman